Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Instil Bio Inc TIL

Healthcare Biotechnology
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a... see more

Recent & Breaking News (NDAQ:TIL)

Till Capital Appoints Alan S. Danson as Director

GlobeNewswire August 21, 2015

Till Capital Names Coeur Communications as Investor Relations Firm

GlobeNewswire August 19, 2015

Till Capital Announces Director and Officer Resignations

GlobeNewswire August 18, 2015

Till Capital Appoints Roger Loeb as Director

GlobeNewswire August 17, 2015

Till Capital Director Blair Shilleto Resigns Due to Family Reasons

GlobeNewswire August 5, 2015

Till Capital Schedules Annual General Meeting

GlobeNewswire August 4, 2015

Till Capital Appoints John T. ("Terry") Rickard as Director

GlobeNewswire August 3, 2015

Till Capital Director David Atkins Will Not Put Name Forward for Reelection

GlobeNewswire July 17, 2015

Till Capital Cancels and Reschedules Annual General Meeting

GlobeNewswire July 16, 2015

Taussig Capital Ltd. Engagement Agreement

GlobeNewswire July 10, 2015

Till Capital Announces Resignation of Director

GlobeNewswire July 6, 2015

Till Capital Names Sard Verbinnen as Investor Relations Firm

GlobeNewswire June 24, 2015

William A. Lupien Appointed to Till Capital Board of Directors

GlobeNewswire June 22, 2015

Till Capital Commences Trading on the Nasdaq Listing

GlobeNewswire May 26, 2015

Till Capital Announces Nasdaq Listing

GlobeNewswire May 21, 2015

Till Capital Announces Completion of Acquisition of Omega Insurance Holdings, Inc.

GlobeNewswire May 19, 2015

Till Capital Releases 2014 Earnings

Filing Services Canada April 29, 2015

Till Capital Receives Note Receivable Payments

Filing Services Canada April 21, 2015

Till Capital Enters into First Reinsurance Policy

Filing Services Canada February 17, 2015

S&P Capital IQ Initiates Coverage on Till Capital Ltd. in S&P Capital IQ Factual Stock Reports

PR Newswire January 6, 2015